// App-Quantinova.ai

225.0 : The impact of neurocognitive function on health utility scores (HUS) in Stage 4 (S4) lung cancer patients (pts) with and without brain metastases (BrM).

Researchers

Presenter

  • Brandon C Tse

Principal Investigators

  • Vivian Tam

  • Tiffany Tse

  • Lin Lu

  • Michael Borean

  • Emily Tam

  • Catherine Labb

  • Mark K. Doherty

  • Penelope Ann Bradbury

  • Natasha B. Leighl

  • M. Catherine Brown

  • Wei Xu

  • Doris Howell

  • Geoffrey Liu

  • Grainne O'Kane

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology and Hematology, Toronto, ON, Canada

  • Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON, Canada

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved